These bills would all save money and they would make a difference for millions of patients around the country. Mr. Dr. Omerski, according to a recent study, Part D Medicare could save as much as $0.06 Billion dollars annually if it were using the same pricing for certain generic drugs as the cost plus drug companies use. In other words, you're getting a better deal for patients while under the part D program. PBMs drive up the cost for seniors and taxpayers. (02:21–02:36)
STATEMENT
Asserts that Part D Medicare could save $0.06 billion annually by adopting cost plus drug company pricing for certain generics.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.